Efficacy of Sacral Nerve Modulation in Severe Refractory Constipation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subjects with refractory chronic constipation are offered two conventional therapeutic strategies: either medical treatment, either surgery (in the case of medication failure). Nevertheless, a procedure less invasive than surgery could be an alternative strategy: the sacral nerve modulation. This procedure consists in stimulating the nerves which control the contractions of the colon and so the defecation phenomenon. Several open trials have suggested that sacral nerve modulation may be effective in reducing constipation and related symptoms. The aim of this randomized clinical trial is to assess the efficacy of the sacral nerve stimulation in patients with constipation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness and Safety of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation

NCT02961465

Constipation Surgery

COMPLETED

Effectiveness of Non-invasive Neuromodulation for Intestinal Transit in Healthy Subjects

NCT06294457

Constipation

NOT_YET_RECRUITING NA

Effect of Lumbo-sacral Magnetic Stimulation on Colonic Motility

NCT00213317

Functional Colonic Disease Fecal Incontinence

COMPLETED

Comparing Manual and Automatic Colonic Massage for Chronic Constipation.

NCT06695754

Chronic Constipation

COMPLETED

Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis

NCT05989763

Systemic Sclerosis Constipation Gastrointestinal Motility Disorder +1 more

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prevalence of constipation is 2-27% in Western countries. For patients failing medical treatment (laxatives, biofeedback), a surgical solution may be considered (subtotal colectomy). But results are variable and it puts them at risk of functional sequelae.

Sacral nerve modulation is a minimally invasive procedure compared with the standard surgical support (colectomy) and reversible, which consists in two stages. First, a 3-week temporary stimulation test allows verifying the efficacy of neuromodulation. If the test is positive, the stimulating electrode is definitely implanted. Risks related to the procedure (infection, pain) are much smaller than those associated with a conventional surgical support.

Non comparative studies conducted with 19 and 62 patients showed that 40-73% of implanted patients have an improvement of their constipation and could benefit of permanent implantation with good results in medium term.

The primary objective of the investigators study is to evaluate the short-term efficacy (percentage of responders at 2 months) of sacral nerve modulation in the treatment of severe chronic constipation.

This is a cross-over designed, double-blinded, French multicenter clinical trial, including two periods: 2 months of stimulation ON and 2 months of stimulation OFF. Between these two periods, a 15-days period of "wash-out" will be respected during which all patients will be in OFF mode (4.5 months in total). This period of 4.5 months will be extended by a follow-up period of 7 months during which all patients will be treated (stimulation ON).

If this trial showed efficiency of this procedure, patients with severe refractory constipation could benefit of a sacral nerve modulation test before considering a surgical treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Constipation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm on-off

After the definitive implantation, stimulators are placed in position OFF during 8 weeks.

Then all the stimulators are switched OFF for 15 days. Finally stimulators are switched ON for the second arm during 8 weeks

Group Type EXPERIMENTAL

sacral nerve modulation

Intervention Type PROCEDURE

After the definitive implantation, stimulators are placed in position ON (arm on-off) or OFF (arm off-on) for the first arm and in position OFF for the second arm during 8 weeks.

Then all the stimulators are switched OFF (both first and second arms) for 15 days.

Finally stimulators are maintained in position OFF for the first arm and switched ON for the second arm during 8 weeks

Arm off-on

After the definitive implantation, stimulators are placed in position ON during 8 weeks.

Then all the stimulators are switched OFF for 15 days. Finally stimulators are maintained in position OFF during 8 weeks

Group Type EXPERIMENTAL

sacral nerve modulation

Intervention Type PROCEDURE

After the definitive implantation, stimulators are placed in position ON (arm on-off) or OFF (arm off-on) for the first arm and in position OFF for the second arm during 8 weeks.

Then all the stimulators are switched OFF (both first and second arms) for 15 days.

Finally stimulators are maintained in position OFF for the first arm and switched ON for the second arm during 8 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sacral nerve modulation

After the definitive implantation, stimulators are placed in position ON (arm on-off) or OFF (arm off-on) for the first arm and in position OFF for the second arm during 8 weeks.

Then all the stimulators are switched OFF (both first and second arms) for 15 days.

Finally stimulators are maintained in position OFF for the first arm and switched ON for the second arm during 8 weeks

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years old
* Constipation defined by at least two of the following criteria :

* Frequency of 2 stools or less per week
* Severe outlet constipation, i.e. need to use digital extraction or enemas more than 25% of time
* Sensation of incomplete evacuation more than 25% of time
* Refractory constipation since at least 1 year to medical treatment (drug treatment and/or biofeedback) conducted in the centre (failure or intolerance to laxative osmotic treatments, stimulants, and prucalopride) for which surgery is discussed
* Patients supported in the centre for at least 3 months before inclusion
* Patients having social security system
* Patients having read and signed informed consent form

Exclusion Criteria

* Constipation secondary to ano-rectal malformation, surgical sequel, colorectal or anal organic lesions, or pelvi-perineal static disorder indicated for surgical treatment
* Constipation secondary to neurological pathology and/or concomitant treatments intake (opiates, anticholinergic agents)
* Partial colectomy history
* Patients in whom implantation of stimulating electrode is impossible due to anatomical reasons (e.g. sacral agenesis)
* Pregnant female patients or with childbearing potential without adequate contraceptive barrier (oestrogen-progesterone contraceptives or intra-uterine device)
* Skin disease associated with a risk of infection - in the opinion of the investigator
* Patient with pacemaker or defibrillator
* Patient exposed to resonance magnetic imaging
* Psychiatric disease incompatible with use of the treatment - in the opinion of the investigator
* Patient misunderstanding oral and written French language
* Patient participating to another study
* Patients who don't complete the first diary without missing data (concerning items used to define the primary endpoint)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No